MaraƱon, Araceli G.
HRN: 23 71 82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/18/2023
CEFTRIAXONE 1G (VIAL)
09/18/2023
09/24/2023
IV
2gm
OD
Cap Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes